
Company Info
Phone(919) 767-3277
Year Established
2014
Ticker
ROIV
Exchange
NASDAQ
Contacts
Matthew GlineCEO
Jo Chen
General Counsel
Eric Venker, MD
President & COO
Richard Pulik
CFO
Srini Ramanathan, PhD
CDO
Amy Mahery
CCO
Company Description
Roivant develops transformative medicines faster by building technologies and developing talent in creative ways, leveraging the Roivant platform to launch Vants - nimble and focused biopharmaceutical and health technology companies.